Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
It’s the latest in several moves — announced in swift succession — that suggest a radical overhaul in Zuckerberg’s thinking about Meta.
Executives at top financial services firms expect to cut as many 200,000 jobs in the next five years and significantly increase revenues.
The investment company says advisors and investors should break from the traditional strategy and take on more defensive positions this year.